Navigating the Complexity of Redefining Obesity Care
Show Notes
Episode Summary
In this episode of In the Know with Nina, Dr. Nina Crowley is joined by Dr. Marc-André Cornier—President of The Obesity Society and Director of Endocrinology at MUSC—to unpack the shifting landscape of obesity diagnosis and treatment.
Their conversation explores the implications of the Lancet Commission’s recommendation to move beyond BMI by introducing new categories like “clinical” and “preclinical” obesity. They discuss what these definitions could mean for real-world care, particularly in pediatrics and early intervention.
Dr. Cornier shares The Obesity Society’s concerns about compounded GLP-1 medications, emphasizing the need for safe, regulated options and multidisciplinary support. He also stresses the importance of integrating body composition analysis into routine care to monitor meaningful health changes—especially in the era of powerful anti-obesity medications.
Whether you’re a clinician, policy advocate, or just interested in where obesity care is headed, this conversation provides critical insights on how to reframe, rethink, and advance obesity treatment.
Key Takeaways
-
Beyond BMI: The Lancet Commission calls for new classifications—like “preclinical” obesity—but concerns remain about access to care and insurance coverage.
-
Why Body Composition Matters: Tools like bioimpedance analysis and DEXA offer deeper insights than BMI, especially when monitoring GLP-1–related weight loss.
-
A Stand Against Compounding: The Obesity Society warns of risks in compounded GLP-1 medications due to unknown purity, efficacy, and payer disincentives.
-
Obesity First: Clinicians must prioritize obesity as a chronic disease—diagnosing and treating it early, just like diabetes or hypertension.
-
The Role of Education: Public understanding of obesity is evolving, but stigma and misinformation remain. Provider advocacy and patient education are essential.
Connect with Dr. Marc-André Cornier
📧 Email: cornier@musc.edu
🔗 Learn more: The Obesity Society
📸 Instagram: @obesitysociety
🔗 LinkedIn: The Obesity Society
Recommended Episodes
Episode 53: Peptides, Products & Promises: Cutting Through the Hype
Dr. Nina Crowley sits down with Dr. Jacqueline Jacques to explore peptides, GLP-1s, and the supplement surge in obesity care. They break down what’s science, what’s spin, and how clinicians can guide patients with evidence and empathy in a noisy marketplace.
Watch episode
Episode 52: Compassion-Driven, Science-Based: A Look Into Modern Obesity Medicine
Dr. Lindsay Ogle joins Nina Crowley to explore a compassionate, virtual-first approach to obesity and metabolic care. They discuss the four pillars of treatment, the power of language, and why non-scale victories matter. Learn how Dr. Ogle is making care more accessible—and more effective—for patients across Missouri.
Watch episode
Episode 51: ROI IRL: How Body Comp Drives Revenue, Retention & Results
In this episode, Dr. Jon Bruce shares how body composition analysis powers his wellness and aesthetics clinic. From preserving muscle to reducing visceral fat, his patients see measurable results—and his practice sees real ROI. Tune in for tips on business strategy, patient motivation, and clinical integration.
Watch episodeseca north america
Medical Measuring Systems and Scales since 1840
13601 Benson AvenueChino, CA 91710
USA
seca Service
As the world leader in medical scales, we also offer you first-class service. Together with our branches, partners and dealers, seca offers a worldwide service network that ensures our products work troublefree.
All rights reserved seca 2023